June 2023 MRD Monitoring by Targeted Mass Spectrometry Allows Early Relapse Detection in MM – Blood 2022
June 2023 An ultra-sensitive method for sequencing and monitoring M-protein in peripheral blood – EMN 2023
June 2023 Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for MRD Monitoring in MM – Clin Chem. 2021
June 2023 Mass Spectrometry for Identification, Monitoring, and MRD Detection of M-Proteins – Clin Chem. 2020
June 2023 Multiple Myeloma MRD Detection: Targeted Mass Spectrometry in Blood vs Next-Generation Sequencing in Bone Marrow – Clin Chem. 2021
June 2023 Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry – Blood Cancer J. 2023
June 2023 IMWG consensus criteria for response and minimal residual disease assessment in Multiple Myeloma – Lancet Oncol. 2016
June 2023 Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma – Front Oncol. 2020
June 2023 Making clinical decisions based on measurable residual disease improves the outcome in Multiple Myeloma – J Hematol Oncol. 2021
